Patents Assigned to IMMUNOTHERAPY DEVELOPMENT INC.
  • DNA VACCINE AGAINST AMYLOID-BETA AND TAU
    Publication number: 20220280619
    Abstract: An object of the present invention is to provide a vaccine that can simultaneously reduce A? deposition and tau deposition in the brain by means of a single molecule. The present invention provides a recombinant vector comprising DNA encoding amyloid-?, DNA encoding an immunoglobulin Fc sequence, and DNA encoding tau.
    Type: Application
    Filed: May 2, 2022
    Publication date: September 8, 2022
    Applicant: IMMUNOTHERAPY DEVELOPMENT INC.
    Inventor: Yoh MATSUMOTO
  • DNA vaccine against amyloid-? and tau
    Patent number: 11351234
    Abstract: An object of the present invention is to provide a vaccine that can simultaneously reduce A? deposition and tau deposition in the brain by means of a single molecule. The present invention provides a recombinant vector comprising DNA encoding amyloid-?, DNA encoding an immunoglobulin Fc sequence, and DNA encoding tau.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: June 7, 2022
    Assignee: IMMUNOTHERAPY DEVELOPMENT INC.
    Inventor: Yoh Matsumoto
  • DNA VACCINE AGAINST AMYLOID-BETA AND TAU
    Publication number: 20180153973
    Abstract: An object of the present invention is to provide a vaccine that can simultaneously reduce A? deposition and tau deposition in the brain by means of a single molecule. The present invention provides a recombinant vector comprising DNA encoding amyloid-?, DNA encoding an immunoglobulin Fc sequence, and DNA encoding tau.
    Type: Application
    Filed: October 20, 2016
    Publication date: June 7, 2018
    Applicant: IMMUNOTHERAPY DEVELOPMENT INC.
    Inventor: Yoh MATSUMOTO